Literature DB >> 27312726

Metabolic disease: FGF1 stops diabetes in its tracks.

Sarah Crunkhorn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27312726     DOI： 10.1038/nrd.2016.122

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Central injection of fibroblast growth factor 1 induces sustained remission of diabetic hyperglycemia in rodents.

Authors:  Jarrad M Scarlett; Jennifer M Rojas; Miles E Matsen; Karl J Kaiyala; Darko Stefanovski; Richard N Bergman; Hong T Nguyen; Mauricio D Dorfman; Louise Lantier; David H Wasserman; Zaman Mirzadeh; Terry G Unterman; Gregory J Morton; Michael W Schwartz
Journal:  Nat Med       Date:  2016-05-23       Impact factor: 53.440
  1 in total
  3 in total

1.  RAGE: A potential therapeutic target during FGF1 treatment of diabetes-mediated liver injury.

Authors:  Peipei Zheng; Zonghao Tang; Jun Xiong; Beini Wang; Jingyu Xu; Lulu Chen; Shufang Cai; Chengbiao Wu; Libing Ye; Ke Xu; Zimiao Chen; Yanqing Wu; Jian Xiao
Journal:  J Cell Mol Med       Date:  2021-03-31       Impact factor: 5.310

2.  Reduction of cellular stress is essential for Fibroblast growth factor 1 treatment for diabetic nephropathy.

Authors:  Yanqing Wu; Yiyang Li; Ting Jiang; Yuan Yuan; Rui Li; Zeping Xu; Xingfeng Zhong; Gaili Jia; Yanlong Liu; Ling Xie; Ke Xu; Hongyu Zhang; Xiaokun Li; Jian Xiao
Journal:  J Cell Mol Med       Date:  2018-10-15       Impact factor: 5.310

3.  Acidic fibroblast growth factor attenuates type 2 diabetes-induced demyelination via suppressing oxidative stress damage.

Authors:  Rui Li; Beini Wang; Chengbiao Wu; Duohui Li; Yanqing Wu; Libing Ye; Luxia Ye; Xiongjian Chen; Peifeng Li; Yuan Yuan; Hongyu Zhang; Ling Xie; Xiaokun Li; Jian Xiao; Jian Wang
Journal:  Cell Death Dis       Date:  2021-01-21       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.